Laboratoires Expanscience
Laboratoires Expanscience, headquartered in France, is a prominent player in the dermo-cosmetics and health sectors. Founded in 1943, the company has established itself as a leader in the formulation of innovative skincare products and active ingredients, particularly through its renowned brands such as Mustela and Eucerin. With a strong presence in Europe, Asia, and the Americas, Laboratoires Expanscience focuses on developing high-quality, eco-friendly products that cater to the needs of sensitive skin. Their commitment to research and development has led to significant milestones, including the introduction of unique active ingredients derived from natural sources. Recognised for its dedication to sustainability and dermatological expertise, Laboratoires Expanscience continues to enhance its market position, making it a trusted name in the beauty and health industries.
DitchCarbon Score
How does Laboratoires Expanscience's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Laboratoires Expanscience's score of 56 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Laboratoires Expanscience's reported carbon emissions
In 2023, Laboratoires Expanscience reported total carbon emissions of approximately 62,628,000 kg CO2e. This figure represents a decrease from 2022, when emissions were about 66,611,000 kg CO2e, indicating a positive trend in their climate performance. The 2022 data also disclosed that approximately 6,661,100 kg CO2e of these emissions were from Scope 1 and 2 sources. Laboratoires Expanscience has set ambitious climate commitments aligned with the Science Based Targets initiative (SBTi). They aim to achieve a 46.2% reduction in absolute Scope 1 and 2 greenhouse gas emissions by 2030, using 2019 as the baseline year. Additionally, they plan to reduce Scope 3 emissions—covering areas such as purchased goods and services, business travel, and downstream transportation—by the same percentage within the same timeframe. Long-term, the company is committed to reaching net-zero emissions across all scopes by 2050, with a target to reduce total emissions by 90% from the 2019 baseline. These commitments reflect Laboratoires Expanscience's dedication to addressing climate change and contributing to global efforts to limit warming to 1.5 °C. The company's initiatives are crucial in the context of the pharmaceuticals and biotechnology sector, where sustainability practices are increasingly vital for operational resilience and corporate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | - |
| Scope 2 | - |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laboratoires Expanscience is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
